Activation of an Interleukin-4 MRNA-producing Population of Peripheral Blood Mononuclear Cells After Infection with Mycobacterium Bovis or Vaccination with Killed, but Not Live, BCG

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1996 Jun 1

PMID 8690460

Citations 5

Authors

S Hook

F Griffin

C Mackintosh

G Buchan

Affiliations

Soon will be listed here.

Abstract

This study examines the expression of mRNA for the Th2 cytokine, interleukin-4 (IL-4). Peripheral blood mononuclear cells from deer infected with Mycobacterium bovis or vaccinated with live or killed M. bovis bacillus Calmette-Guérin (BCG) were cultured with mycobacterial antigens. IL-4 mRNA production was assayed using the polymerase chain reaction. Elevated levels of IL-4 mRNA were detected in response to at least one antigen preparation in all animals infected with M. bovis as compared with none of the non-infected control animals. After a primary immunization, elevated levels of IL-4 mRNA were detected in only a proportion of vaccinated animals and this did not correlate with whether the vaccine was live BCG or killed BCG in oil. After boosting, all the animals vaccinated with killed BCG in oil exhibited elevated IL-4 mRNA production whereas none of the animals vaccinated with live BCG showed elevated levels. The data suggest that IL-4 is turned off during the immune response to live BCG, that boosting of low-dose live BCG vaccine may be required to 'imprint' this signal and that this may be important in the development of protective immunity to tuberculosis. Killed BCG in adjuvant is not protective and as with experimental infection with virulent M. bovis it failed to switch off the IL-4 response. IL-4 may be useful as a diagnostic tool and as an in vitro marker of vaccine efficacy.

Citing Articles

Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.

Young S, Slobbe L, Wilson R, Buddle B, de Lisle G, Buchan G Infect Immun. 2007; 75(6):2833-40.

PMID: 17371857 PMC: 1932853. DOI: 10.1128/IAI.01826-06.

Immunoglobulin G1 enzyme-linked immunosorbent assay for diagnosis of Johne's Disease in red deer (Cervus elaphus).

Griffin J, Spittle E, Rodgers C, Liggett S, Cooper M, Bakker D Clin Diagn Lab Immunol. 2005; 12(12):1401-9.

PMID: 16339063 PMC: 1317074. DOI: 10.1128/CDLI.12.12.1401-1409.2005.

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.

Skinner M, Ramsay A, Buchan G, Keen D, Ranasinghe C, Slobbe L Immunology. 2003; 108(4):548-55.

PMID: 12667217 PMC: 1782916. DOI: 10.1046/j.1365-2567.2003.01589.x.

An in vivo comparison of bacillus Calmette-Guérin (BCG) and cytokine-secreting BCG vaccines.

Slobbe L, Lockhart E, ODonnell M, Mackintosh C, De Lisle G, Buchan G Immunology. 1999; 96(4):517-23.

PMID: 10233736 PMC: 2326794. DOI: 10.1046/j.1365-2567.1999.00702.x.

Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival.

Chandra R Proc Natl Acad Sci U S A. 1996; 93(25):14304-7.

PMID: 8962043 PMC: 34479. DOI: 10.1073/pnas.93.25.14304.

References

Bretscher P . A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today. 1992; 13(9):342-5. DOI: 10.1016/0167-5699(92)90168-7. View

Daugelat S, Ladel C, Kaufmann S . Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun. 1995; 63(5):2033-40. PMC: 173261. DOI: 10.1128/iai.63.5.2033-2040.1995. View

Griffin J, Cross J, Chinn D, Rodgers C, Buchan G . Diagnosis of tuberculosis due to Mycobacterium bovis in New Zealand red deer (Cervus elaphus) using a composite blood test and antibody assays. N Z Vet J. 1994; 42(5):173-9. DOI: 10.1080/00480169.1994.35815. View

Saito S, Dorf M, Watanabe N, Tadakuma T . Preferential induction of IL-4 is determined by the type and duration of antigenic stimulation. Cell Immunol. 1994; 153(1):1-8. DOI: 10.1006/cimm.1994.1001. View

Sanchez F, Rodriguez J, Agudelo G, Garcia L . Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun. 1994; 62(12):5673-8. PMC: 303319. DOI: 10.1128/iai.62.12.5673-5678.1994. View

Fine P . The BCG story: lessons from the past and implications for the future. Rev Infect Dis. 1989; 11 Suppl 2:S353-9. DOI: 10.1093/clinids/11.supplement_2.s353. View

Firestein G, Roeder W, Laxer J, Townsend K, Weaver C, Hom J . A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol. 1989; 143(2):518-25. View

Gray D . Immunological memory. Annu Rev Immunol. 1993; 11:49-77. DOI: 10.1146/annurev.iy.11.040193.000405. View

Surcel H, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G . Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 1994; 81(2):171-6. PMC: 1422315. View

10.

Griffin J, Buchan G . Vaccination against tuberculosis: is BCG more sinned against than sinner?. Immunol Cell Biol. 1993; 71 ( Pt 5):431-42. DOI: 10.1038/icb.1993.49. View

11.

Hook S, Crawford A, Chinn D, Griffin J, Buchan G . Cloning and expression of the cervine interleukin 4 gene. Scand J Immunol. 1994; 40(1):71-6. DOI: 10.1111/j.1365-3083.1994.tb03435.x. View

12.

Buchan G, Griffin J . Tuberculosis in domesticated deer (Cervus elaphus): a large animal model for human tuberculosis. J Comp Pathol. 1990; 103(1):11-22. DOI: 10.1016/s0021-9975(08)80131-4. View

13.

Kelso A, Groves P, Troutt A, Francis K . Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol. 1995; 25(5):1168-75. DOI: 10.1002/eji.1830250506. View

14.

Coffman R, Varkila K, Scott P, Chatelain R . Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev. 1991; 123:189-207. DOI: 10.1111/j.1600-065x.1991.tb00611.x. View

15.

Kollias Jr G, Thoen C, Fowler M . Evaluation of comparative cervical tuberculin skin testing in cervids naturally exposed to mycobacteria. J Am Vet Med Assoc. 1982; 181(11):1257-62. View

16.

Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R . Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136(7):2348-57. View

17.

Orme I, Roberts A, Griffin J, Abrams J . Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol. 1993; 151(1):518-25. View

18.

Griffin J, Mackintosh C, Buchan G . Animal models of protective immunity in tuberculosis to evaluate candidate vaccines. Trends Microbiol. 1995; 3(11):418-24. DOI: 10.1016/s0966-842x(00)88994-5. View

19.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

20.

Hernandez-Pando R, Rook G . The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology. 1994; 82(4):591-5. PMC: 1414923. View